Influenza: girding for disaster. Facing down pandemic flu, the world's defenses are weak.
Jocelyn
J
Kaiser
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019049:Developed Countries; D003906:Developing Countries; D004196:Disease Outbreaks / Q000517:prevention & control*; D014943:Global Health; D006801:Humans; D009980:Influenza A virus / Q000276:immunology / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000600:supply & distribution; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000276:immunology / Q000472:pathogenicity; D010330:Patents as Topic; D014481:United States; D014614:Vaccines, Synthetic
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D007252:Influenza Vaccines; D014614:Vaccines, Synthetic